Reaping NIS 11.78 billion in tax savings between 2006 and 2011 under an Israeli government program to encourage capital investment, Teva Pharmaceutical Industries placed first in a list published Tuesday by the Israel Tax Authority of publicly-traded companies benefiting from the tax breaks.